Developing regions vs Egypt: Proportion of the target population who received
Developing regions
75.0%
in 2024
Egypt
96.0%
in 2024
Developing regions rank
9th
Egypt rank
24th
Proportion of the target population who received over time
- Developing regions
- Egypt
How they compare
Egypt currently reports 96.0% against 75.0% in Developing regions, a difference of 21.0%.
That makes Egypt's figure about 1.3 times Developing regions's.
Across all 25 years both countries report, Egypt has been ahead every year.
Developing regions ranks 9th and Egypt ranks 24th of 23 groups.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Developing regions | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.2% | 96.8% | 73.6% | Egypt |
| 2010s | 56.0% | 94.5% | 38.5% | Egypt |
| 2020s | 71.0% | 95.4% | 24.4% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Developing regions or Egypt?
- Egypt, at 96.0% against 75.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received between Developing regions and Egypt?
- 21.0%, with Egypt ahead.
- How many years of comparable data are there for Developing regions and Egypt?
- 25 years are reported by both, from 2000 to 2024.
- How do Developing regions and Egypt rank globally for proportion of the target population who received?
- Developing regions ranks 9th and Egypt ranks 24th of 23 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.